NDC 68727-745 – Vyxeos
Cytarabine 100 mg/20mL; Daunorubicin 44 mg/20mL · Injection, Powder, Lyophilized, For Suspension · Intravenous
Product NDC68727-745
Product details
- Brand name
- Vyxeos
- Generic name
- (daunorubicin and cytarabine) liposome
- Labeler
- Jazz Pharmaceuticals, Inc.
- Dosage form
- Injection, Powder, Lyophilized, For Suspension
- Route
- Intravenous
- Marketing category
- NDA · NDA209401
- Marketed since
- August 3, 2017
- Listing expires
- December 31, 2027
- Pharmacologic class
- Anthracycline Topoisomerase Inhibitor; Nucleoside Metabolic Inhibitor
Active ingredients
- Cytarabine 100 mg/20mL
- Daunorubicin 44 mg/20mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 68727-745-01 | 20 mL in 1 VIAL (68727-745-01) | Aug 3, 2017 |
| 68727-745-02 | 40 mL in 1 CARTON (68727-745-02) | Aug 3, 2017 |